Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.Financial_Report.xls
10-Q - GENESIS BIOPHARMA FORM 10-Q - Lion Biotechnologies, Inc.gnbp10q093012.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R25.htm
EX-31.2 - EXHIBIT 31.2 - Lion Biotechnologies, Inc.ex312.htm
EX-31.1 - EXHIBIT 31.1 - Lion Biotechnologies, Inc.ex311.htm
EX-32.1 - EXHIBIT 32.1 - Lion Biotechnologies, Inc.ex321.htm
EX-32.2 - EXHIBIT 32.2 - Lion Biotechnologies, Inc.ex322.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R26.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Lion Biotechnologies, Inc.R12.htm
v2.4.0.6
Condensed Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended 60 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Income Statement [Abstract]          
Revenues $ 0 $ 0 $ 0 $ 0 $ 0
Costs and expenses          
Operating expenses (including $697,671, $532,511, $2,357,370, $10,783,000 and $4,265,240 in share-based compensation costs) 1,377,636 5,814,141 5,003,840 17,033,575 25,025,332
Research and development 250,000 0 1,406,000 0 3,333,045
Impairment of intangible asset 0 0 0 0 160,036
Total costs and expenses 1,627,636 5,814,141 6,409,840 17,033,575 28,518,413
Loss from operations (1,627,636) (5,814,141) (6,409,840) (17,033,575) (28,518,413)
Other income (expense)          
Change in fair value of derivative liability 1,595,933 3,546,042 975,698 3,241,440 2,342,506
Interest expense (126,924) (31,644) (326,561) (31,644) (477,714)
Amortization of discount on convertible notes 0 (2,598,425) (497,888) (2,598,425) (5,497,888)
Private placement costs (515,269) (920,310) (515,269) (920,310) (1,998,927)
Total other income (expense) 953,739 (4,337) (364,020) (308,939) (5,632,023)
Net Loss $ (673,896) $ (5,818,478) $ (6,773,860) $ (17,342,514) $ (34,150,436)
Net Loss Per Share, Basic and Diluted $ (0.01) $ (0.07) $ (0.09) $ (0.23)  
Weighted-Average Common Shares Outstanding, Basic and Diluted 78,293,095 78,299,552 78,240,952 74,755,735